Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2005; 11(47): 7436-7443
Published online Dec 21, 2005. doi: 10.3748/wjg.v11.i47.7436
Figure 6
Figure 6 Incidence of intestinal metaplasia distant from the anastomosis site (A) and esophageal adenocarcinoma (B). The risk of both intestinal metaplasia and adenocarcinoma was significantly lower in the SOD-treated group than in the control group (P = 0.046 and P = 0.021, respectively) (n = 6-10).